Evidence map›Paper›PMID 35062670›Full record

ArticleVaccines2021

The Effectiveness of Post-Vaccination and Post-Infection Protection in the Hospital Staff of Three Prague Hospitals: A Cohort Study of 8-Month Follow-Up from the Start of the COVID-19 Vaccination Campaign (COVANESS).

Marek Petráš, Ivana Králová Lesná, Livia Večeřová, Elka Nyčová, Jana Malinová, Petr Klézl, Martina Nezvedová, Rachel Elizabeth White, Roman Máčalík, Jana Dáňová and 2 more

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Marek PetrášThird Faculty of Medicine, Charles University, 100 00 Prague, Czech Republic.ORCID 0000-0003-2913-1736
Ivana Králová LesnáInstitute for Clinical and Experimental Medicine, 140 21 Prague, Czech Republic.ORCID 0000-0002-9053-4123
Livia VečeřováBulovka University Hospital, 180 00 Prague, Czech Republic.
Elka NyčováBulovka University Hospital, 180 00 Prague, Czech Republic.
Jana MalinováKrálovské Vinohrady University Hospital, 100 34 Prague, Czech Republic.
Petr KlézlKrálovské Vinohrady University Hospital, 100 34 Prague, Czech Republic.
Martina NezvedováKrálovské Vinohrady University Hospital, 100 34 Prague, Czech Republic.
Rachel Elizabeth WhiteKrálovské Vinohrady University Hospital, 100 34 Prague, Czech Republic.
Roman MáčalíkThird Faculty of Medicine, Charles University, 100 00 Prague, Czech Republic.
Jana DáňováThird Faculty of Medicine, Charles University, 100 00 Prague, Czech Republic.
Alexander M ČelkoThird Faculty of Medicine, Charles University, 100 00 Prague, Czech Republic.
Věra AdámkováInstitute for Clinical and Experimental Medicine, 140 21 Prague, Czech Republic.
Charles University · CZUniversity Hospital Kralovske Vinohrady · CZFakultní nemocnice Bulovka · CZInstitute of Clinical and Experimental Medicine · CZ

Funding

Charles University, Czech Republic UK PROGRES Q16-Environmental research project
6 · The paper itself

Abstract

Continuous assessment of the effectiveness of approved COVID-19 vaccines is crucial to gain an insight into the longer-term impact on health outcomes, and eventually boosting public confidence. For this reason, we conducted a multicenter, retrospective cohort study using data on infection and vaccination rates among employees of three Prague hospitals in the period between 27 December 2020 and 31 August 2021. The post-vaccination and post-infection protectiveness were assessed in a total of 11,443 hospital workers who were followed up for more than 14 days either after their Comirnaty vaccination or study enrolment, depending on their previous SARS-CoV-2 infection. The effectiveness of full vaccination against any SARS-CoV-2 infection achieved 88.3% (83.2-91.8%) over the eight months of follow-up, a figure not much different from the 92.5% (76.5-97.6%) level of protection built by a previous infection. Despite this, the post-vaccination level of protection declined to about 65% between June and August. No case of breakthrough infection was registered among hospital workers having received one or two vaccine doses more than three months after previous infection. The eight-month effectiveness of the Comirnaty vaccine exhibited a declining trend requiring a new booster dose. The need for vaccination in the previously infected employees was not demonstrated conclusively in this study.

Indexed as

breakthrough infectionCOVID-19 vaccinationeffectivenesshospital workersreinfection

Identifiers

PMID35062670
PMCPMC8779277
OpenAlexW4200485395

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.